These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 23625947)

  • 1. Structural determinants of agonist efficacy at the glutamate binding site of N-methyl-D-aspartate receptors.
    Hansen KB; Tajima N; Risgaard R; Perszyk RE; Jørgensen L; Vance KM; Ogden KK; Clausen RP; Furukawa H; Traynelis SF
    Mol Pharmacol; 2013 Jul; 84(1):114-27. PubMed ID: 23625947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-based discovery of antagonists for GluN3-containing N-methyl-D-aspartate receptors.
    Kvist T; Greenwood JR; Hansen KB; Traynelis SF; Bräuner-Osborne H
    Neuropharmacology; 2013 Dec; 75():324-36. PubMed ID: 23973313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of subunit selectivity for competitive NMDA receptor antagonists with preference for GluN2A over GluN2B subunits.
    Lind GE; Mou TC; Tamborini L; Pomper MG; De Micheli C; Conti P; Pinto A; Hansen KB
    Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6942-E6951. PubMed ID: 28760974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-channel properties of N-methyl-D-aspartate receptors containing chimaeric GluN2A/GluN2D subunits.
    O'Leary T; Wyllie DJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1347-54. PubMed ID: 19909274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural determinants and mechanism of action of a GluN2C-selective NMDA receptor positive allosteric modulator.
    Khatri A; Burger PB; Swanger SA; Hansen KB; Zimmerman S; Karakas E; Liotta DC; Furukawa H; Snyder JP; Traynelis SF
    Mol Pharmacol; 2014 Nov; 86(5):548-60. PubMed ID: 25205677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Negative allosteric modulation of GluN1/GluN3 NMDA receptors.
    Zhu Z; Yi F; Epplin MP; Liu D; Summer SL; Mizu R; Shaulsky G; XiangWei W; Tang W; Burger PB; Menaldino DS; Myers SJ; Liotta DC; Hansen KB; Yuan H; Traynelis SF
    Neuropharmacology; 2020 Oct; 176():108117. PubMed ID: 32389749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An alternating GluN1-2-1-2 subunit arrangement in mature NMDA receptors.
    Riou M; Stroebel D; Edwardson JM; Paoletti P
    PLoS One; 2012; 7(4):e35134. PubMed ID: 22493736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of AICP as a GluN2C-Selective
    Jessen M; Frederiksen K; Yi F; Clausen RP; Hansen KB; Bräuner-Osborne H; Kilburn P; Damholt A
    Mol Pharmacol; 2017 Aug; 92(2):151-161. PubMed ID: 28588066
    [No Abstract]   [Full Text] [Related]  

  • 9. Arrangement of subunits in functional NMDA receptors.
    Salussolia CL; Prodromou ML; Borker P; Wollmuth LP
    J Neurosci; 2011 Aug; 31(31):11295-304. PubMed ID: 21813689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chimeric Glutamate Receptor Subunits Reveal the Transmembrane Domain Is Sufficient for NMDA Receptor Pore Properties but Some Positive Allosteric Modulators Require Additional Domains.
    Wilding TJ; Lopez MN; Huettner JE
    J Neurosci; 2016 Aug; 36(34):8815-25. PubMed ID: 27559165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local constraints in either the GluN1 or GluN2 subunit equally impair NMDA receptor pore opening.
    Talukder I; Wollmuth LP
    J Gen Physiol; 2011 Aug; 138(2):179-94. PubMed ID: 21746848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational changes at the agonist binding domain of the N-methyl-D-aspartic acid receptor.
    Rambhadran A; Gonzalez J; Jayaraman V
    J Biol Chem; 2011 May; 286(19):16953-7. PubMed ID: 21454656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural features of the glutamate binding site in recombinant NR1/NR2A N-methyl-D-aspartate receptors determined by site-directed mutagenesis and molecular modeling.
    Chen PE; Geballe MT; Stansfeld PJ; Johnston AR; Yuan H; Jacob AL; Snyder JP; Traynelis SF; Wyllie DJ
    Mol Pharmacol; 2005 May; 67(5):1470-84. PubMed ID: 15703381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycine agonism in ionotropic glutamate receptors.
    Stroebel D; Mony L; Paoletti P
    Neuropharmacology; 2021 Aug; 193():108631. PubMed ID: 34058193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desensitization of NMDA channels requires ligand binding to both GluN1 and GluN2 subunits to constrict the pore beside the activation gate.
    Chen YS; Tu YC; Lai YC; Liu E; Yang YC; Kuo CC
    J Neurochem; 2020 Jun; 153(5):549-566. PubMed ID: 31821563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GluN1 splice variant control of GluN1/GluN2D NMDA receptors.
    Vance KM; Hansen KB; Traynelis SF
    J Physiol; 2012 Aug; 590(16):3857-75. PubMed ID: 22641781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel family of negative and positive allosteric modulators of NMDA receptors.
    Costa BM; Irvine MW; Fang G; Eaves RJ; Mayo-Martin MB; Skifter DA; Jane DE; Monaghan DT
    J Pharmacol Exp Ther; 2010 Dec; 335(3):614-21. PubMed ID: 20858708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heteromerization of ligand binding domains of N-methyl-D-aspartate receptor requires both coagonists, L-glutamate and glycine.
    Cheriyan J; Mezes C; Zhou N; Balsara RD; Castellino FJ
    Biochemistry; 2015 Jan; 54(3):787-94. PubMed ID: 25544544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subtype-Specific Agonists for NMDA Receptor Glycine Binding Sites.
    Maolanon AR; Risgaard R; Wang SY; Snoep Y; Papangelis A; Yi F; Holley D; Barslund AF; Svenstrup N; Hansen KB; Clausen RP
    ACS Chem Neurosci; 2017 Aug; 8(8):1681-1687. PubMed ID: 28514141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitatory amino acid responses in relay neurons of the rat lateral geniculate nucleus.
    Harata N; Katayama J; Akaike N
    Neuroscience; 1999 Mar; 89(1):109-25. PubMed ID: 10051221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.